# EDGAR Filing Document

**Accession Number:** 0001787740
**File Stem:** 0001683168-25-005418
**Filing Date:** 2025-7
**Character Count:** 36386
**Document Hash:** 08d9ddc4a74d63c1ed8cecd270e1d2ed
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-25-005418.hdr.sgml**: 20250725

**ACCESSION NUMBER**: 0001683168-25-005418

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 5

**FILED AS OF DATE**: 20250725

**DATE AS OF CHANGE**: 20250725

**EFFECTIVENESS DATE**: 20250725

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tivic Health Systems, Inc.
- **CENTRAL INDEX KEY:** 0001787740
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 814016391
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-288968
- **FILM NUMBER:** 251152234

**BUSINESS ADDRESS:**
- **STREET 1:** 47685 LAKEVIEW BLVD
- **CITY:** FREMONT
- **STATE:** CA
- **ZIP:** 94538
- **BUSINESS PHONE:** (888)276-6888

**MAIL ADDRESS:**
- **STREET 1:** 47685 LAKEVIEW BLVD
- **CITY:** FREMONT
- **STATE:** CA
- **ZIP:** 94538

**As filed with the Securities and Exchange Commission on July 25, 2025**

**Registration No. 333-** 

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT**

**UNDER**

**THE SECURITIES ACT OF 1933**

**Tivic Health Systems, Inc.**

(Exact name of Registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **81-4016391** |
| (State or other jurisdiction of<br> incorporation or organization) | (I.R.S. Employer<br> Identification Number) |

---

**47685 Lakeview Blvd.**

**Fremont, California 94538<br> (888) 276-6888**<br> (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

**TIVIC HEALTH SYSTEMS, INC. 2021 EQUITY INCENTIVE PLAN**

(Full title of the plans)

**Jennifer Ernst<br> Chief Executive Officer<br> 47685 Lakeview Blvd.**

**Fremont, California 94538<br> (888) 276-6888**

(Name, address, including zip code, and telephone number, including area code, of agent for service)

***Copies to*:**

**Christopher L. Tinen, Esq.**

**Caitlin Murphey, Esq.<br> Snell & Wilmer L.L.P.<br> 3611 Valley Centre Drive, Suite 500**

**San Diego, CA 92130**

**(858) 910-4809**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ◻

**REGISTRATION OF ADDITIONAL SHARES PURSUANT TO GENERAL INSTRUCTION E**

Tivic Health Systems, Inc. (the "Company") is filing this Registration Statement on Form S-8 (this "Registration Statement") for the purpose of registering an aggregate of 511,117 additional shares of Company common stock, par value $0.0001 per share ("Common Stock"), issuable pursuant to the Tivic Health Systems, Inc. 2021 Equity Incentive Plan, as amended and restated on August 9, 2024 and as further amended on June 30, 2025 (as amended to date, the "2021 Plan"), which includes (i) 53,389 additional shares of Common Stock added to the 2021 Plan in connection with the amendment and restatement of the 2021 Plan on August 9, 2024; (ii) 286 shares, 284 shares, 4,312 shares, and 27,846 additional shares of Common Stock added to the 2021 Plan on January 1, 2022, January 1, 2023, January 1, 2024, and January 1, 2025, respectively, pursuant to the "evergreen" provision of the 2021 Plan; and (iii) 425,000 additional shares of Common Stock added to the 2021 Plan in connection with the amendment of the 2021 Plan on June 30, 2025. The "evergreen" provision of the 2021 Plan provides that the number of shares of Common Stock available for issuance under the 2021 Plan will automatically increase on the first day of each fiscal year during the term of the 2021 Plan, beginning on January 1, 2022 and ending on (and including) January 1, 2031, in an amount equal to the lesser of (a) five percent (5%) of the total number of shares of the Company's Common Stock outstanding on December 31<sup>st</sup> of the precedent calendar year and (b) such number of shares determined by the Company's board of directors.

The Company initially registered 552 shares and 222 shares of Common Stock reserved for issuance under the 2021 Plan and the Company's 2017 Equity Incentive Plan (the "2017 Plan"), respectively, on Form S-8 filed with the Securities and Exchange Commission (the "Commission") on November 12, 2021 (Commission File No. 333-261044), the contents of which are hereby incorporated by reference into this Registration Statement, except to the extent supplemented, amended or superseded by the information set forth in this Registration Statement or by any subsequently filed document.

On August 23, 2023, the Company effected a 1-for-100 reverse stock split of the Company's issued and outstanding shares of Common Stock (the "First Reverse Stock Split"). On March 7, 2025, the Company effected a 1-for-17 reverse stock split of the Company's issued and outstanding shares of Common Stock (the "Second Reverse Stock Split"). All share and per share data from the periods prior to August 23, 2023 and March 7, 2025 included in this Registration Statement, including without limitation the number of shares of Common Stock registered pursuant to the Prior Registration Statement and the number of shares that may be issued pursuant to the 2021 Plan, has been retroactively adjusted to reflect the First Reverse Stock Split and Second Reverse Stock Split, respectively.

**PART I**

**INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS**

The information called for in Part I of Form S-8 to be contained in the Section 10(a) prospectus is not being filed with or included in this Registration Statement (by incorporation by reference or otherwise) in accordance with the rules and regulations of the Commission. The documents containing the information specified in Part I of Form S-8 will be delivered to the recipient of the Inducement Grant covered by this Registration Statement, as specified by Rule 428(b)(1) of the Securities Act of 1933, as amended (the "Securities Act").

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

**Item 3. Incorporation of Documents by Reference.**

The following documents, which have been filed by the Company with the Commission pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act"), are incorporated herein by reference:

· the Company's Annual Report on [Form 10-K](http://www.sec.gov/Archives/edgar/data/1787740/000095017025043234/tivc-20241231.htm) for the fiscal year ended December 31, 2024, filed with the Commission on March 21, 2025 (the "Annual Report");

· the Company's Quarterly Report on [Form 10-Q](http://www.sec.gov/Archives/edgar/data/1787740/000095017025072752/tivc-20250331.htm) filed with the Commission on May 15, 2025; and

· the Company's Current Reports on Form 8-K and 8-K/A filed with the Commission on [January 3, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025001140/tivc-20241227.htm) , [February 5, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025014601/tivc-20250131.htm) , [February 12, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025018419/tivc-20250210.htm) , [February 24, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025025238/tivc-20250218.htm) , [March 5, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025033091/tivc-20250304.htm) , [March 6, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025034191/tivc-20250306.htm) , [March 21, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025043166/tivc-20250318.htm) , [April 3, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025050485/tivc-20250328.htm) , [April 10, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025052679/tivc-20250404.htm) , [April 14, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025053769/tivc-20250414.htm) , [April 22, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025056480/tivc-20250422.htm) , [May 2, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025062733/tivc-20250429.htm) , [May 14, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025070948/tivc-20250509.htm) , [May 20, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025075301/tivc-20250520.htm) , [June 25, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025089741/tivc-20250625.htm) , [July 7, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025094222/tivc-20250630.htm) and [July 25, 2025](https://www.sec.gov/ix?doc=/Archives/edgar/data/1787740/000095017025098773/tivc-20250618.htm) (provided that any portions of such reports that are deemed furnished and not filed pursuant to instructions
 to Form 8-K shall not be incorporated by reference into this prospectus); and

· the description of the Company's Common Stock contained in the Company's Registration Statement on [Form 8-A](http://www.sec.gov/Archives/edgar/data/1787740/000110465921136539/tm2132372d1_8a12b.htm) filed with the Commission on November 10, 2021 (File No. 001-41052), including any amendment or report filed for the purpose of updating such description, and [Exhibit 4.4](http://www.sec.gov/Archives/edgar/data/1787740/000110465922041068/tm229804d2_ex4-4.htm) of the Annual Report.

All reports and other documents filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits furnished on such form that relate to such items, after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this Registration Statement from the date of filing such reports and documents.

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

**Item 8. Exhibits.**

The exhibits to this Registration Statement are listed in the below Exhibit Index and are incorporated by reference herein.

---

| | |
|:---|:---|
| **Exhibit<br> Number** | **Exhibit Description** |
| 4.1 | [Amended and Restated Certificate of Incorporation of Tivic Health Systems, Inc., dated November 12, 2021](http://www.sec.gov/Archives/edgar/data/1787740/000110465921139122/tm2132951d1_ex3-1.htm) (incorporated by reference to Exhibit 3.1 to the Company's Annual Report on Form 10-K, filed with the Commission on November 15, 2021). |
| 4.2 | [Amended and Restated Bylaws of Tivic Health Systems, Inc.](http://www.sec.gov/Archives/edgar/data/1787740/000110465921139122/tm2132951d1_ex3-2.htm) (incorporated by reference to Exhibit 3.2 to the Company's Annual Report on Form 10-K, filed with the Commission on November 15, 2021). |
| 4.3 | [Certificate of Amendment to the Amended and Restated Bylaws of Tivic Health Systems, Inc., dated July 5, 2023](http://www.sec.gov/Archives/edgar/data/1787740/000095017023032062/tivc-ex3_1.htm) (incorporated by reference to Exhibit 3.3 to the Company's Annual Report on Form 10-K, filed with the Commission on July 6, 2023). |
| 4.4 | [Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Tivic Health Systems, Inc., filed August 21, 2023](http://www.sec.gov/Archives/edgar/data/1787740/000095017023043808/tivc-ex3_1.htm) (effective August 23, 2023) (incorporated by reference to Exhibit 3.4 to the Company's Annual Report on Form 10-K, filed with the Commission on August 22, 2023). |
| 4.5 | [Certificate of Designation of Series A Non-Voting Convertible Preferred Stock of Tivic Health Systems, Inc., dated February 10, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025072752/tivc-ex3_1.htm) (incorporated by reference to Exhibit 3.1 to the Company's Quarterly Report on Form 10-Q, filed with the Commission on May 15, 2025). |
| 4.6 | [Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Tivic Health Systems, Inc., filed March 4, 2025 (effective March 7, 2025)](http://www.sec.gov/Archives/edgar/data/1787740/000095017025033091/tivc-ex3_1.htm) (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K, filed with the Commission on March 5, 2025). |
| 4.7 | [Certificate of Designation of Series B Non-Voting Convertible Preferred Stock of Tivic Health Systems, Inc., dated April 29, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025072752/tivc-ex3_3.htm) (incorporated by reference to Exhibit 3.3 to the Company's Quarterly Report on Form 10-Q, filed with the Commission on May 15, 2025). |
| 5.1\* | [Opinion of Snell & Wilmer L.L.P.](tivic_ex0501.htm) |
| 23.1\* | [Consent of Rosenberg Rich Baker Berman, P.A.](tivic_ex2301.htm) |
| 23.2\* | Consent of Snell & Wilmer L.L.P. (included in [Exhibit 5.1](tivic_ex0501.htm)). |
| 24.1\* | [Power of Attorney](#poa) (included on signature page). |
| 99.1 | [Tivic Health Systems, Inc. 2021 Equity Incentive Plan](http://www.sec.gov/Archives/edgar/data/1787740/000110465921114256/tm2115690d8_ex10-4a.htm) (incorporated by reference to Exhibit 10.4(a) to the Company's Registration Statement on Form S-1, filed with the Commission on September 9, 2021 (File No. 333-258411)). |
| 99.2 | [Tivic Health System, Inc. Amended and Restated 2021 Equity Incentive Plan, dated August 13, 2024](http://www.sec.gov/Archives/edgar/data/1787740/000095017024096305/tivc-ex10_1.htm) (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed with the Commission on August 13, 2024). |
| 99.3 | [Form Agreements under Tivic Health Systems, Inc. 2021 Equity Incentive Plan](http://www.sec.gov/Archives/edgar/data/1787740/000110465921114256/tm2115690d8_ex10-4b.htm) (incorporated by reference to Exhibit 10.4(b) to the Company's Registration Statement on Form S-1, filed with the Commission on September 9, 2021 (File No. 333-258411)). |
| 99.4 | [First Amendment to Tivic Health Systems, Inc. Amended and Restated 2021 Equity Incentive Plan, dated June 30, 2025](http://www.sec.gov/Archives/edgar/data/1787740/000095017025094222/tivc-ex10_2.htm) (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K, filed with the Commission on July 7, 2025). |
| 107\* | [Filing Fee Table](tivic_ex107.htm). |

---

\* Filed herewith

**Item 9. Undertakings.**

(a) The undersigned registrant hereby undertakes:

(1) to file, during any period in which offers or sales are being made, a post-effective amendment to this
Registration Statement:

(i) to include any prospectus required by Section 10(a)(3) of the Securities Act;

(ii) to reflect in the prospectus any facts or events arising after the effective date of this registration
statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change
in the information set forth in this registration statement;

(iii) to include any material information with respect to the plan of distribution not previously disclosed
in this registration statement or any material change to such information in this registration statement; *provided, however*, that
paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13
or Section 15(d) of the Exchange Act that are incorporated by reference in this registration statement;

---

| | |
|:---|:---|
| *provided*, *however*, that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement. | *provided*, *however*, that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement. |
| (2) | that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial *bona fide* offering thereof; and |
| (3) | to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |

---

(b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the
Securities Act, each filing of the registrant's annual report pursuant to Section 13(a) or 15(d) of the Exchange
Act that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be the initial *bona fide* offering
thereof.

(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors,
officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised
that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities
Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by
the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of
any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered,
the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Securities Act and will be
governed by the final adjudication of such issue.

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Fremont, State of California on July 25, 2025.

---

| | |
|:---|:---|
| **TIVIC HEALTH SYSTEMS, INC.** | **TIVIC HEALTH SYSTEMS, INC.** |
| By: | /s/ Jennifer Ernst |
|  | Jennifer Ernst |
|  | Chief Executive Officer |

---

**POWER OF ATTORNEY**

Each person whose signatures appears below constitutes and appoints Jennifer Ernst and Lisa Wolf his or her true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8 to be filed by Tivic Health Systems, Inc., and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitutes, may lawfully do or cause to be done by virtue hereof.

\*\*\*

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Jennifer Ernst | Chief Executive Officer | July 25, 2025 |
| Jennifer Ernst | (Principal Executive Officer) |  |
| /s/ Lisa Wolf | Chief Financial Officer | July 25, 2025 |
| Lisa Wolf | (Principal Financial and Accounting Officer) |  |
| /s/ Sheryle Bolton | Chair of the Board | July 25, 2025 |
| Sheryle Bolton |  |  |
| /s/ Christina Valauri | Director | July 25, 2025 |
| Christina Valauri |  |  |
| /s/ Dean Zikria | Director | July 25, 2025 |
| Dean Zikria |  |  |

---

## Exhibit 5.1

**Exhibit 5.1**

![](image_001.jpg)

July 25, 2025

Tivic Health Systems, Inc.

47685 Lakeview Blvd.

Fremont, CA 94538

**Re: Registration Statement on Form S-8**

Ladies and Gentlemen:

We have acted as counsel to Tivic Health Systems, Inc., a Delaware corporation (the "Company"), in connection with the preparation and filing with the Securities and Exchange Commission (the "Commission") of a Registration Statement on Form S-8 for the registration of 511,117 shares of common stock of the Company, $0.0001 par value per share (the "Shares"), issuable pursuant to the Company's Amended and Restated 2021 Equity Incentive Plan, as amended (the "Plan").

This opinion is being furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act in connection with the filing of the Registration Statement, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the related prospectus, other than as expressly stated herein with respect to the issuance of the Shares.

In connection with this letter, we have examined originals, or copies certified or otherwise identified to our satisfaction, of (i) the Amended and Restated Certificate of Incorporation of the Company, as amended, as currently in effect, (ii) the Amended and Restated Bylaws of the Company, as amended, as currently in effect, (iii) the Plan, (iv) the Registration Statement, (v) a certificate executed by an officer of the Company, dated as of the date hereof, as to certain factual matters, and (vi) such other corporate documents and records as we deemed appropriate for purposes of the opinions set forth herein. For the purpose of rendering this opinion, we have made such factual and legal examinations as we deemed necessary under the circumstances, and in that connection therewith we have examined, among other things, originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate records, certificates of public officials, certificates of officers or other representatives of the Company, and other instruments and have made such inquiries as we have deemed appropriate for the purpose of rendering this opinion.

In our examination, we have assumed without independent verification the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic, certified, conformed or photostatic copies, and the authenticity of the originals of such copies. In making our examination of executed documents, we have assumed that the parties thereto, other than the Company, had the power, corporate or other, to enter into and perform all obligations thereunder and have also assumed the due authorization by all requisite action, corporate or other, and the execution and delivery by such parties of such documents and the validity and binding effect thereof on such parties. Our opinions are subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar laws affecting creditors' rights and remedies generally, and subject, as to enforceability, to general principles of equity, including principles of commercial reasonableness, good faith and fair dealing (regardless of whether enforcement is sought in a proceeding at law or in equity). As to any facts material to the opinions expressed herein which were not independently established or verified, we have relied upon oral or written statements and representations of officers or other representatives of the Company and others.

![](image_001.jpg)

On the basis of, and in reliance on, the foregoing examination and subject to the assumptions, exceptions, qualifications and limitations contained herein, we are of the opinion that the Shares have been duly authorized and, when issued in accordance with the terms of the Plan against payment of the consideration required by the Plan, will be validly issued, fully paid and non-assessable.

The opinion expressed herein is limited to the Delaware General Corporation Law and reported judicial decisions applicable thereto. We neither express nor imply any obligation with respect to any other laws or the laws of any other jurisdiction or of the United States. For purposes of this opinion, we assume that the Shares will be issued in compliance with all applicable state securities or blue sky laws.

We assume no obligation to update or supplement this opinion if any applicable laws change after date of this opinion or if we become aware after the date of this opinion of any facts, whether existing before or arising after the date hereof, that might change the opinions expressly so stated. Without limiting the generality of the foregoing, we neither express nor imply any opinion regarding the contents of the Registration Statement, other than as expressly stated herein with respect to the Shares.

We are opining only as to matters expressly set forth herein, and no opinion should be inferred as to any other matters. This opinion is rendered as of the date hereof and is based upon currently existing statutes, rules, regulations and judicial decisions. We disclaim any obligation to advise you of any change in any of these sources of law or subsequent legal or factual developments that affect any matters or opinions set forth herein.

We hereby consent to the filing of this opinion letter with the Commission as Exhibit 5.1 to the Registration Statement filed by the Company. In giving such consent, we do not thereby concede that we are included in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

Very truly yours,

<u>/s/ Snell & Wilmer L.L.P.</u>

Snell & Wilmer L.L.P.

## Exhibit 23.1

**Exhibit 23.1**

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 21, 2025 (which includes an explanatory paragraph relating to Tivic Health Systems, Inc.'s ability to continue as a going concern) relating to the financial statements of Tivic Health Systems, Inc. as of and for the years ended December 31, 2024 and 2023.

/s/ Rosenberg Rich Baker Berman, P.A.

Somerset, New Jersey

July 25, 2025

## Ex-Filing

**Exhibit 107**

**CALCULATION OF FILING FEE TABLES**

Form S-8

**(Form Type)**

Tivic Health Systems, Inc.

**(Exact Name of Registrant as Specified in its Charter)**

<u>Table 1: Newly Registered Securities</u>

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Security<br> Type | Security Class Title | Fee<br> Calculation<br> or Carry<br> Forward<br> Rule | Amount<br> Registered (1) | Proposed<br> Maximum<br> Offering<br> Price Per<br> Share | Proposed<br> Maximum<br> Aggregate<br> Offering<br> Price | Fee Rate | Amount of<br> Registration<br> Fee | |
| Newly Registered Securities | Newly Registered Securities | Newly Registered Securities | Newly Registered Securities | Newly Registered Securities | Newly Registered Securities | Newly Registered Securities | Newly Registered Securities | Newly Registered Securities |  |
| Fees to be<br> Paid | Equity | Common Stock,<br> $0.0001 par<br> value per<br> share | Rule 457(h); Rule 457(c) | 511117(2) | $4.07(3) | $2080246.19 | $0.00015310 | $318.49 |  |
| Fees<br> Previously<br> Paid |  |  |  |  |  |  |  |  |  |
| Carry Forward Securities | Carry Forward Securities | Carry Forward Securities | Carry Forward Securities | Carry Forward Securities | Carry Forward Securities | Carry Forward Securities | Carry Forward Securities | Carry Forward Securities |  |
| Carry<br> Forward<br> Securities |  |  |  |  |  |  |  |  |  |
|  | Total Offering Amounts | Total Offering Amounts | Total Offering Amounts | Total Offering Amounts |  |  |  | $318.49 |  |
|  | Total Fees Previously Paid | Total Fees Previously Paid | Total Fees Previously Paid | Total Fees Previously Paid |  |  |  | - |  |
|  | Total Fees Offsets | Total Fees Offsets | Total Fees Offsets | Total Fees Offsets |  |  |  | $318.49 |  |
|  | Net Fee Due | Net Fee Due | Net Fee Due | Net Fee Due |  |  |  | $0.00 | (4) |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the "Securities
Act"), this Registration Statement shall also cover any additional shares of common stock, par value $0.0001 per share ("Common
Stock"), of Tivic Health Systems, Inc. (the "Company") that become issuable under the Company's Amended and Restated
2021 Equity Incentive Plan, as amended (the "Plan"), by reason of any stock dividend, stock split, recapitalization or other
similar transaction.

&nbsp;&nbsp;&nbsp;&nbsp;(2) Represents 511,117 shares of Common Stock issuable pursuant to Plan, which includes
(i) 53,389 additional shares of Common Stock added to the Plan in connection with the amendment and restatement of the Plan on August
9, 2024; (ii) 286 shares, 284 shares, 4,312 shares, and 27,846 additional shares of Common Stock added to the Plan on January 1, 2022,
January 1, 2023, January 1, 2024, and January 1, 2025, respectively, pursuant to the "evergreen" provision of the Plan; and
(iii) 425,000 additional shares of Common Stock added to the Plan in connection with the amendment of the Plan on June 30, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;(3) Estimated solely for the purpose of calculating the amount of the registration
fee in accordance with Rules 457(c) and 457(h) of the Securities Act. The proposed maximum offering price per share is based upon the
average of the high and low prices of the Company's Common Stock, as reported on the Nasdaq Capital Market on July 18, 2025, a date
within five business days prior to the filing of the Registration Statement.

&nbsp;&nbsp;&nbsp;&nbsp;(4) See Table 2.

<u>Table 2: Fee Offset Claims and Sources</u>

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Registrant<br> or Filer<br> Name | Form<br> or<br> Filing<br> Type | File<br> Number | Initial<br> Filing<br> Date | Filing<br> Date | Fee<br> Offset<br> Claimed | Security<br> Type<br> Associated<br> with Fee<br> Offset<br> Claimed | Security<br> Title<br> Associated<br> with Fee<br> Offset<br> Claimed | Unsold<br> Securities<br> Associated<br> with Fee<br> Offset<br> Claimed | Unsold<br> Aggregate<br> Offering<br> Amount<br> Associated<br> with Fee<br> Offset<br> Claimed | Fee<br> Paid<br> with<br> Fee<br> Offset<br> Source |
| Rules 457(b) and 0-11(a)(2) | Rules 457(b) and 0-11(a)(2) | Rules 457(b) and 0-11(a)(2) | Rules 457(b) and 0-11(a)(2) | Rules 457(b) and 0-11(a)(2) | Rules 457(b) and 0-11(a)(2) | Rules 457(b) and 0-11(a)(2) | Rules 457(b) and 0-11(a)(2) | Rules 457(b) and 0-11(a)(2) | Rules 457(b) and 0-11(a)(2) | Rules 457(b) and 0-11(a)(2) | Rules 457(b) and 0-11(a)(2) |
| Fee Offset<br> Claims |  |  |  |  |  |  |  |  |  |  |  |
| Fee Offset<br> Sources |  |  |  |  |  |  |  |  |  |  |  |
| Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) | Rule 457(p) |
| Fee Offset<br> Claims | Tivic Health Systems, Inc. | S-1 | 333-268010 (1) | October 26, 2022 |  | $318.49 | Equity | Common Stock,<br> $0.0001 par<br> value per<br> share | (1) | (1) |  |
|  | Tivic Health Systems, Inc. | S-1 | 333-268010 (1) | October 26, 2022 |  | $0.00 | Equity | Common Stock<br> Underlying<br> Representative's<br> Warrants | (1) | (1) |  |
| Fee Offset<br> Source | Tivic Health Systems, Inc. | S-1 | 333-268010 (1) |  | October 26, 2022 |  |  |  |  |  | $7025.25 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) On October 26, 2022, the Registrant filed a Registration Statement on Form S-1
(File No. 333-268010) (the "2022 S-1") with the Securities and Exchange Commission (the "SEC"), which registered
an aggregate principal amount of $63,750,000 of the Registrant's common stock and representative warrants to purchase common stock,
to be offered by the Registrant; the fee amount paid in connection with the 2022 S-1 was $7,025.25, as calculated in accordance with Rule
457 of the Securities Act. On February 1, 2023, the Registrant filed a fourth amendment to the 2022 S-1, pursuant to which it registered
only an aggregate amount of $6,109,375 in value of the Registrant's securities that were sold (the "Final Offering");
the fee amount attributable to such sale of securities in the Final Offering was $673.26, as calculated in accordance with Rule 457 of
the Securities Act. As a result, after the Final Offering, which has been completed as of the date hereof, the Registrant had $6,351.99
in unused filing fees previously paid by the Registrant in connection with its filing of the 2022 S-1 (as amended). The Registrant filed
a new Registration Statement on Form S-1 with SEC on March 29, 2024 (the "2024 S-1"), followed by a first amendment to the
2024 S-1 on May 8, 2024, for which it offset $3,661.66 of the filing fees due in connection therewith by the unused filing fees previously
paid by the Registrant in connection with its filing of the 2022 S-1 (as amended), resulting in $2,690.33 in remaining unused fees available
to be applied to future filings of the Registrant. The Registrant filed a new Registration Statement on Form S-1 with SEC on May 9, 2025
(the "2025 S-1"), for which it offset $193.45 of the filing fees due in connection therewith by the unused filing fees previously
paid by the Registrant in connection with its filing of the 2022 S-1 (as amended), resulting in $2,496.88 in remaining unused fees available
to be applied to future filings of the Registrant. In accordance with Rule 457(p) under the Securities Act, the registrant is using $318.49
of the aforementioned unused filing fees previously paid by the Registrant in connection with its filing of the 2022 S-1 (as amended)
to offset the entirety of the filing fee payable in connection with this Registration Statement, and as a result of such offset, the Registrant
will have $2,178.39 remaining in unused filing fees available to be applied to future filings of the Registrant.